Sentences with phrase «regenerative medicine research at»
During his tenure at the University of Florida, he was active in the feral cat spay and neuter program, developed an interest in orthopedic and neurosurgery for cats and dogs and participated in regenerative medicine research at the College of Medicine.
http://www.animalspecialtycenter.com/ Not exact matches
The new tower will also host the Medicine by Design initiative, set to become a leading centre in regenerative medicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research ExcellenMedicine by Design initiative, set to become a leading centre in regenerative medicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research Excellenmedicine at the University of Toronto with the federal government committing $ 114 - million for this project through the Canada First Research Excellence Fund.
At GFI, David combines his background in plant biology and regenerative medicine to help companies and academic research institutions accelerate the development of plant - based and clean meat alternatives to animal products.
In a groundbreaking study that provides scientists with a critical new understanding of stem cell development and its role in disease, UCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research led by Dr. Kathrin Plath, professor of biological chemistry, have established a first - of - its - kind methodology that defines the unique stages by which specialized cells are reprogrammed into stem cells that resemble those found in the embryo.
The team at the University's Medical Research Council Centre for Regenerative Medicine were surprised to find the molecules can also boost direct conversions from one type of mature cell to another — including transforming skin cells into brain cells.
«It's a stellar piece of work — the fact they were able to achieve the precise shape they need is impressive,» says Charles Vacanti, director of the Laboratory for Tissue Engineering and Regenerative Medicine at Brigham and Women's Hospital in Boston, who did not take part in this research.
«Despite new therapies, it's virtually inevitable that a patient with multiple myeloma will experience relapse of the disease at some point,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, Koman Family Presidential Endowed Chair in Cancer Research and chief of the Division of Regenerative Medicine at UC San Diego School of Mmedicine, Koman Family Presidential Endowed Chair in Cancer Research and chief of the Division of Regenerative Medicine at UC San Diego School of MMedicine at UC San Diego School of MedicineMedicine.
Pleasure, who is research director at Shriner's Hospital for Children Northern California and also directs the Institute for Pediatric Regenerative Medicine, noted that considerable research interest has arisen about the use of minocycline for diseases of the central nervous system because of the increasing evidence about its neuroprotective effects.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Center for Duchenne Muscular Dystrophy at UCLA have developed a new approach that could eventually be used to treat Duchenne muscular dystrophy.
Now commander of the Dental and Trauma Research Detachment at the U.S. Army Institute of Surgical Research in San Antonio, he has brought the best and brightest minds of regenerative and transplant medicine to the task of healing some of the most grievous wounds of modern warfare.
But a number of the invited speakers, including Alan Trounson, president of the California Institute for Regenerative Medicine in San Francisco, and keynote speaker George Daley, a stem - cell scientist at Children's Hospital Boston in Massachusetts, are involved in research using human embryonic stem cells, which the Catholic Church considers unethical.
The U.S. Department of Defense, which received a congressional windfall of $ 80 million to research regenerative medicine in 2008, is funding a team of scientists based at the University of Pittsburgh's McGowan Institute for Regenerative Medicine to oversee an 80 - patient study of ECM at five iregenerative medicine in 2008, is funding a team of scientists based at the University of Pittsburgh's McGowan Institute for Regenerative Medicine to oversee an 80 - patient study of ECM at five instimedicine in 2008, is funding a team of scientists based at the University of Pittsburgh's McGowan Institute for Regenerative Medicine to oversee an 80 - patient study of ECM at five iRegenerative Medicine to oversee an 80 - patient study of ECM at five instiMedicine to oversee an 80 - patient study of ECM at five institutions.
«We knew this gene's alteration likely contributed to schizophrenia and we wanted to better understand how,» said Mei, chairman of the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University, Georgia Research Alliance Eminent Scholar in Neuroscience and a corresponding author of the study in the journal PNAS.
«Our paper is a blueprint of how the cartilage - producing cell, called a chondrocyte, is made and maintained by Sox9,» said He, a postdoctoral research associate in the lab of Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Researchresearch associate in the lab of Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell ResearchResearch at USC.
In a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a «roadmap» for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodies.
The multidisciplinary team behind the current study includes world - renowned researchers in the field of regenerative medicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical Universitregenerative medicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inmedicine and tissue engineering; Paolo Macchiarini, MD, PhD, Director of the Advanced Center for Regenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical UniversitRegenerative Medicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine and senior scientist at Karolinska Institutet; Doris Taylor, PhD, Regenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical UniversitRegenerative Medicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine Research Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inResearch Director at the Texas Heart Institute; and Mark Holterman, MD, PhD, Professor of Surgery and Pediatrics at the University of Illinois College of Medicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inMedicine in Peoria, working in collaboration with a research team at the Kuban State Medical University inresearch team at the Kuban State Medical University in Russia.
«Heart calcification has been understudied and underreported,» says senior author Arjun Deb, of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research based at the University of California, Los Angeles.
Dr Stephen Simpson, director of research and programmes at Arthritis Research UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint conditionresearch and programmes at Arthritis Research UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint conditionResearch UK added: «This is exciting, novel work in the field of regenerative medicine, which although in its early experimental stages, could take us a step closer to our ultimate goal of a more effective and much - needed new treatment for the very many people who live with this painful joint condition.»
The work and the researchers involved were supported by grants from the National Institutes of Health, California Institute of Regenerative Medicine, the Nomis Foundation, the Della Thome Foundation, the Bundy Foundation, the Hewitt Foundation, the Paul F. Glenn Center for Aging Research at the Salk Institute and the Waitt Foundation.
Vishlaghi created these «minibrains» at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, where she's a research asResearch at UCLA, where she's a research asresearch assistant.
The study was funded by grants from Federal Ministry of Education and Research, Germany; National Institutes of Health (EY018213, EY001919, EY020846, DK042394, DK088227, and HL052173); Foundation Fighting Blindness; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; NHS Foundation Trust; UCL Institute of Ophthalmology; Fight For Sight; Moorfields Eye Hospital Special Trustees; and Barbara & Donald Jonas Laboratory of Stem Cells and Regenerative Medicine, Bernard & Shirlee Brown Glaucoma Laboratory, the Joan and Michael Schneeweiss Stem Cell Fund and Research to Prevent Blindness.
The study was published in the journal PLOS Biology by co-senior author Bennett Novitch, member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and collaborators from the Francis Crick Institute in London, U.K..
«The results were remarkable, with significant shrinkage in patient - derived tumors,» said Memarzadeh, who also is an associate professor of obstetrics and gynecology and the director of the G.O. Discovery Laboratory at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and associate professor.
«Because of relatively low survival rates and their advancing age, these patients tend to be poor candidates for aggressive therapies, like a bone marrow transplant,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, chief of the Division of Regenerative Medicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores Cancermedicine, chief of the Division of Regenerative Medicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores CancerMedicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores CancerMedicine and director of the Stem Cell Research Program at Moores Cancer Center.
«We concluded that RAC1 regulates lung branching morphogenesis, in part through the so - called canonical Wnt signaling pathway, which leads to the regulation of the transcription of many genes,» said principal investigator Denise Al Alam, PhD, of the Department of Surgery and the Developmental Biology and Regenerative Medicine Program at The Saban Research Institute.
Dr. Lei Li and Dr. Xiang - Dong Sun, Fellows and co-authors and Dr. Lin Mei, chairman of the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University and Georgia Research Alliance Eminent Scholar in Neuroscience.
On the surface of our numerous star - shaped brain cells called astrocytes, they have found the molecule LRP4 is important in ensuring healthy levels of a brain chemical that enables learning and memory, said Dr. Lin Mei, chairman of the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University and Georgia Research Alliance Eminent Scholar in Neuroscience.
A short rundown of the achievements of Atala and his research team at the Wake Forest Institute for Regenerative Medicine strains credulity.
Several large GDNF - related research projects taking shape at Cedars - Sinai are funded by the California Institute for Regenerative Medicine.
«It's probably premature to run large trials without evidence that they have a therapeutic effect that [we] understand,» cautions Arnold Kriegstein, director of the Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, San Francisco.
«I think this is an extremely important — and solid — paper,» says stem cell researcher Robert Lanza, vice president of research and scientific development at Applied Cell Technology, a regenerative medicine company headquartered in Alameda, Calif., who did not take part in the study.
UCLA researchers led by Drs. Peiyee Lee and Richard Gatti at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells (iPSC) to advance disease - in - a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia (A-T).
The study was published in the journal Nature Cell Biology by senior author April Pyle, associate professor of microbiology, immunology and molecular genetics and member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.
«Essentially, they cause acetylcholine to build up in the brain, causing hyperexcitability of neurons as well as the death of some neurons, which leads to inflammation in the brain,» said Ashok K. Shetty, PhD, a professor in the Department of Molecular and Cellular Medicine at the Texas A&M College of Medicine, associate director of the Institute for Regenerative Medicine, research career scientist at the Olin E. Teague Veterans Medical Center, Central Texas Veterans Health Care System and senior author of the paper.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have, for the first time, coaxed human stem cells to become sensory interneurons — the cells that give us our sense of touch.
«Our research shows that cells derived from corneal stem cells are attractive candidates for generating corneal cells in the laboratory,» said Alexander Ljubimov, PhD, director of the Eye Program at the Board of Governors Regenerative Medicine Institute and principal investigator on this research study.
«Therapies for metastatic prostate cancer are urgently needed,» said Dr. Owen Witte, founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, university professor of microbiology, immunology and molecular genetics at the UCLA David Geffen School of Medicine, and a senior author of the paper.
A team of scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) discovered a new bone - forming growth factor, Osteolectin (Clec11a), which reverses osteoporosis in mice and has implications for regenerative medicine.
FORT LAUDERDALE / DAVIE, Fla. — Leading faculty members from the Nova Southeastern University (NSU) College of Allopathic Medicine (M.D. College) are scheduled to present their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell SummitMedicine (M.D. College) are scheduled to present their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell Summitmedicine at the 2018 World Stem Cell Summit (WSCS).
Co-organizers are the Regenerative Medicine Foundation, Karolinska Institute, Maryland Stem Cell Research Fund / TEDCO, Mayo Clinic, The New York Stem Cell Foundation, Nova Southeastern University and NSU Cell Therapy Institute, The Cure Alliance, Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine, University of Florida Center for Regenerative Medicine, Wake Forest Institute for Regenerative Medicine, and Weill Cornell Medicine.
New research by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastresearch by scientists at the Pennsylvania Cancer and Regenerative Medicine Research Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breastResearch Center, a division of the Baruch S. Blumberg Institute, shows that medicines currently used in HIV treatment may help to target chemotherapy for breast cancer.
An anonymous donor made a $ 100,000 contribution to advance research at the Department of Rehabilitation & Regenerative Medicine.
Our research is located at the interface of immunology and stem cell research and our recent findings lay the groundwork for new cellular therapy approaches in regenerative medicine.
Professor Nakatsuji has been at the forefront of cutting edge work done in Japan, which is a great global collaborative hub for stem cell research and regenerative medicine whose regenerative market is growing exponentially.
Sanford Consortium for Regenerative Medicine, which brings together five of the world's top research institutions — UC San Diego, Sanford - Burnham Medical Research Institute, Salk Institute for Biological Studies, The Scripps Research Institute, and La Jolla Institute for Allergy and Immunology — opens a $ 127 million facility at UC Saresearch institutions — UC San Diego, Sanford - Burnham Medical Research Institute, Salk Institute for Biological Studies, The Scripps Research Institute, and La Jolla Institute for Allergy and Immunology — opens a $ 127 million facility at UC SaResearch Institute, Salk Institute for Biological Studies, The Scripps Research Institute, and La Jolla Institute for Allergy and Immunology — opens a $ 127 million facility at UC SaResearch Institute, and La Jolla Institute for Allergy and Immunology — opens a $ 127 million facility at UC San Diego.
Organized by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceRegenerative Medicine (ARM), the California Institute for Regenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science intMedicine (ARM), the California Institute for Regenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceRegenerative Medicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science intMedicine (CIRM), and the Sanford Consortium for Regenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceRegenerative Medicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science intMedicine, the 2013 Stem Cell Meeting on the Mesa is a three - day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell scienceregenerative medicine industry with the scientific research community to advance stem cell science intmedicine industry with the scientific research community to advance stem cell science into cures.
The meeting also features a nationally recognized Scientific Symposium, to be held October 16 at the Salk Institute for Biological Studies, showcasing leading academic research in the field of regenerative medicine.
«Our study shows that this unique stem cell - based retinal implant thus far is well - tolerated, and preliminary results suggest it may help people with advanced dry age - related macular degeneration,» says coauthor and lead inventor of the implant Dr. Mark S. Humayun, MD, director of the USC Institute for Biomedical Therapeutics, co-director of the USC Roski Eye Institute, affiliate principal investigator with the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC and university professor of ophthalmology at the Keck School.
July 2010 - Urban Lendahl Heads New Research Centre EuroSyStem PI Urban Lendahl named as Scientific Director of the Wallenberg Institute for Regenerative Medicine EuroSyStem PI Urban Lendahl will be the Scientific Director of a new regenerative medicine research centre at the Karolinska Instituet in StResearch Centre EuroSyStem PI Urban Lendahl named as Scientific Director of the Wallenberg Institute for Regenerative Medicine EuroSyStem PI Urban Lendahl will be the Scientific Director of a new regenerative medicine research centre at the Karolinska Instituet iRegenerative Medicine EuroSyStem PI Urban Lendahl will be the Scientific Director of a new regenerative medicine research centre at the Karolinska Instituet in StMedicine EuroSyStem PI Urban Lendahl will be the Scientific Director of a new regenerative medicine research centre at the Karolinska Instituet iregenerative medicine research centre at the Karolinska Instituet in Stmedicine research centre at the Karolinska Instituet in Stresearch centre at the Karolinska Instituet in Stockholm.
Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).